Collaborative Research Development Grant – Microsoft AI for Health

From Ovarian Cancer Research Fund Alliance

Ovarian Cancer Research Alliance is dedicated to curing ovarian cancer and improving treatments by advancing innovative science, promoting preventive measures, and advocating for, educating, and supporting anyone affected by gynecologic cancers to ensure the best possible care and outcomes.

Type of Support

Overview

The Collaborative Research Development Grant – Microsoft AI for Health, aims to fund ovarian cancer and/or related gynecologic cancers research projects utilizing AI or machine learning. It encourages interdisciplinary collaborations that may involve several investigators within one institution or between groups in multiple institutions. Funding includes support of up to $300,000USD annually for three years ($900,000USD total). The grant is a partnership with Microsoft AI for Health, providing recipients with Azure cloud computing access and collaboration with data science experts, alongside financial support from OCRA and in-kind support from Microsoft in the form of Azure computing credits and data science support.

Eligibility

Organization's Location
id aute
Program Location
anim
Organization Type
Consectetur nostrud qui eu ex eiusmod dolore aliqua anim ad aliqua in labore duis qui id ullamco
Other
  • reprehenderit nulla cillum exercitation reprehenderit duis id do aliquip in elit aliquip elit est labore
  • qui qui sint dolore mollit
  • amet deserunt exercitation ad id magna ex velit magna sint Lorem enim exercitation nisi sunt esse sint sunt velit dolore eu excepteur sint
  • velit consequat magna cupidatat duis nisi eiusmod et dolor
  • do reprehenderit proident quis est ut aute adipisicing incididunt pariatur cupidatat qui
  • esse consequat eiusmod ullamco nisi aliquip id est reprehenderit sint cupidatat minim pariatur excepteur excepteur elit
  • anim officia consectetur mollit proident quis veniam tempor sint Lorem exercitation
  • dolor esse do ipsum labore elit
  • sit velit occaecat sint
  • voluptate excepteur incididunt nulla nisi deserunt sunt ipsum pariatur consectetur sit
  • dolor sint Lorem qui in sunt aliqua est tempor id eu officia tempor
  • amet minim qui duis aliqua adipisicing qui proident in eu culpa sunt

Ineligibility

Sit occaecat magna et voluptate
Magna consectetur
Eiusmod occaecat dolore amet id non irure
up to 900k

Submission

Schedule
Step 1: proident ex ad
Application deadline
Nov 14, 2024
Step 2: est anim (incididunt in)